Off-label and unlicensed drug use: Results from a pilot study in a paediatric intensive care unit

Other users also viewed these articles

Use of off-label drugs in neonatal intensive care Andrea Sucasas Alonso, Alejandro Avila-Alvarez, Marina Combarro Eiriz, Cristina Martínez Roca, Pedro Yáñez Gómez, Alejandra Codias López, Jose Luis Fernández Trisac, Sonia Pértega Díaz

10.1016/j.anpede.2018.12.005

Comparative assessment of off-label and unlicensed drug prescription in neonatal intensive care: FDA versus Brazilian guidelines Haline Tereza Matias Lima Costa, Arlan Peres Florencio, Priscilla Karilline do Vale Bezerra, Jéssica Escorel Chaves Cavalcanti, Tatiana Xavier Costa, Flavia Evelyn Medeiros Fernandes, Martins Rand Randall

10.1016/j.anpede.2020.07.007

Results from the 2012–2013 paediatric national survey on off-label drug use in children in Spain (OL-PED study) Roi Piñeiro Pérez, María Belén Ruiz Antorán, Cristina Avedaño Solá, Enriqueta Román Riechmann, Lourdes Cabrera García, María José Cilleruelo Ortega, María José Mellado Peña

10.1016/j.anpede.2013.10.003